APA引用形式

Birkeland, E., Busch, C., Berge, E. O., Geisler, J., Jönsson, G., Lillehaug, J. R., . . . Lønning, P. E. (2013). Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma. Springer Netherlands.

シカゴスタイル引用形

Birkeland, Einar, Christian Busch, Elisabet Ognedal Berge, Jürgen Geisler, Göran Jönsson, Johan Richard Lillehaug, Stian Knappskog, , Per Eystein Lønning. Low BRAF and NRAS Expression Levels Are Associated With Clinical Benefit From DTIC Therapy and Prognosis in Metastatic Melanoma. Springer Netherlands, 2013.

MLA引用形式

Birkeland, Einar, et al. Low BRAF and NRAS Expression Levels Are Associated With Clinical Benefit From DTIC Therapy and Prognosis in Metastatic Melanoma. Springer Netherlands, 2013.

警告: この引用は必ずしも正確ではありません.